Durham, NORTH%20CAROLINA9 Active Studies

Prostate Cancer Clinical Trials in Durham, NORTH%20CAROLINA

Find 9 actively recruiting prostate cancer clinical trials in Durham, NORTH%20CAROLINA. Connect with local research sites and explore new treatment options.

9
Active Trials
7
Sponsors
784
Enrolling

Recruiting Prostate Cancer Studies in Durham

RecruitingDurham, NORTH%20CAROLINANCT06785636

Open-Label Study of Pocenbrodib Alone and in Combination With Abiraterone Acetate, Olaparib, or 177Lu-PSMA-617

This is a dose-finding study to assess the safety and preliminary antitumor activity of Pocenbrodib alone or with Abiraterone acetate, Olaparib or 177Lu-PSMA-617 in patients with metastatic castration...

252 participants
Pathos AI, Inc.
View Study Details
RecruitingDurham, NORTH%20CAROLINANCT05832086

Intermittent Fasting Using a Fasting-Mimicking Diet to Improve Prostate Cancer Control and Metabolic Outcomes

This is a Phase 2, randomized two-armed, multi-site study of 138 patients with metastatic castrate sensitive prostate adenocarcinoma. Patients will be randomized 1:1 to receive the fasting mimicking d...

138 participants
Stephen Freedland
View Study Details
RecruitingDurham, NORTH%20CAROLINANCT06022822

Placebo-Controlled Trial of Urolithin A Supplementation in Men With Prostate Cancer Undergoing Radical Prostatectomy, URO-PRO Trial

This phase II randomized control trial assesses the effect of Urolithin A (Uro-A) supplementation compared to placebo in men with biopsy-confirmed prostate cancer undergoing radical prostatectomy (RP)...

90 participants
National Cancer Institute (NCI)
View Study Details
RecruitingDurham, NORTH%20CAROLINANCT06549465

Study Evaluating Dosimetry, Randomized Dose Optimization, Dose Escalation and Efficacy of Ac-225 Rosopatamab Tetraxetan in Participants With PSMA PET-Positive Castration-Resistant Prostate Cancer (CRPC)

This is a three-part study evaluating the safety and efficacy of a PSMA-directed radioantibody (rosopatamab tetraxetan, conjugated to either In-111 or Ac-225). Part 1 will consist of one administratio...

60 participants
Convergent Therapeutics
View Study Details
RecruitingDurham, NORTH%20CAROLINANCT06228053

Study of SX-682 Plus Enzalutamide in Men With Abiraterone-Resistant Metastatic Castration Resistant Prostate Cancer

The goal of this clinical trial is to study the combination of SX-682 plus enzalutamide in men with metastatic castration resistant prostate cancer (mCRPC) who have failed abiraterone....

53 participants
Syntrix Biosystems, Inc.
View Study Details
RecruitingDurham, NORTH%20CAROLINANCT05011383

High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers

This study will determine whether the presence of DNA repair deficiency in the form of alterations in the genes ATM, CDK12 or CHEK2 predicts for a high likelihood of responding to the use of intermitt...

51 participants
VA Office of Research and Development
View Study Details
RecruitingDurham, NORTH%20CAROLINANCT03824652

WALNUTS for POWER: Polyphenols, Omega-3 Fatty Acids, Weight Loss, and EneRgy

This is a randomized control trial testing the effect of walnut supplementation on prostate cancer progression in 50 men with biopsy confirmed prostate cancer and planning to undergo RP. Patients cons...

50 participants
Stephen Freedland
View Study Details
RecruitingDurham, NORTH%20CAROLINANCT06457919

A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer

The purpose of this study is to find out whether tinengotinib in combination with abiraterone acetate and prednisone or enzalutamide is a safe treatment that causes few or mild side effects in people ...

50 participants
Memorial Sloan Kettering Cancer Center
View Study Details
RecruitingDurham, NORTH%20CAROLINANCT04104893

A Study of CHeckpoint Inhibitors in Men With prOgressive Metastatic Castrate Resistant Prostate Cancer Characterized by a Mismatch Repair Deficiency or Biallelic CDK12 Inactivation

The primary objective is to assess the activity and efficacy of pembrolizumab, a checkpoint inhibitor, in Veterans with metastatic castration-resistant prostate cancer (mCRPC) characterized by either ...

40 participants
VA Office of Research and Development
View Study Details

About Prostate Cancer Clinical Trials in Durham

Prostate cancer develops in the prostate gland and is one of the most common cancers in men. Many prostate cancers grow slowly, but some can be aggressive. Treatment options range from active surveillance to surgery, radiation, and hormone therapy.

There are currently 9 prostate cancer clinical trials recruiting participants in Durham, NORTH%20CAROLINA. These studies are seeking a combined 784 participants. Research is being sponsored by Pathos AI, Inc., Stephen Freedland, National Cancer Institute (NCI) and 4 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Prostate Cancer Clinical Trials in Durham — FAQ

Are there prostate cancer clinical trials in Durham?

Yes, there are 9 prostate cancer clinical trials currently recruiting in Durham, NORTH%20CAROLINA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Durham?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Durham research site will contact you about next steps.

Are clinical trials in Durham free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Durham studies also compensate for your time and travel.

What prostate cancer treatments are being tested?

The 9 active trials in Durham are testing new therapies including novel drugs, biologics, and treatment approaches for prostate cancer.

Data updated March 2, 2026 from ClinicalTrials.gov